Genentech Kidney Cancer Treatment Reduces Worsening Of Disease In Some Patients

In clinical trial, the Tecentriq and Avastin combination met the co-primary endpoint of investigator-assessed progression-free survival compared with sunitinib for certain people with advanced kidney cancer.